Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/896747/000114420414019165/v372214_10k.htm
March 2023
February 2023
December 2022
June 2022
March 2022
December 2021
November 2021
October 2021
August 2021
June 2021
Document And Entity Information (USD $) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2013 | Mar. 28, 2014 | Jun. 28, 2013 | |
Document Information [Line Items] | |||
Entity Registrant Name | AMERICAN BIO MEDICA CORP | ||
Entity Central Index Key | 0000896747 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Filer Category | Smaller Reporting Company | ||
Trading Symbol | ABMC | ||
Entity Common Stock, Shares Outstanding | 23,168,155 | ||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2013 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2013 | ||
Entity Well-known Seasoned Issuer | No | ||
Entity Voluntary Filers | No | ||
Entity Current Reporting Status | Yes | ||
Entity Public Float | $ 2,762,000 |
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/896747/000114420414019165/v372214_10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by American Bio Medica Corp.
American Bio Medica Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
American Bio Medica Corp provided additional information to their SEC Filing as exhibits
Ticker: ABMC
CIK: 896747
Form Type: 10-K Annual Report
Accession Number: 0001144204-14-019165
Submitted to the SEC: Mon Mar 31 2014 12:38:16 PM EST
Accepted by the SEC: Mon Mar 31 2014
Period: Tuesday, December 31, 2013
Industry: Pharmaceutical Preparations